Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Work
Year: 2019
Type: article
Abstract: Nivolumab plus ipilimumab or nivolumab alone resulted in longer progression-free and overall survival than ipilimumab alone in a trial involving patients with advanced melanoma. We now report 5-year o... more
Source: New England Journal of Medicine
Authors James Larkin, Vanna Chiarion‐Sileni, René González, Jean‐Jacques Grob, Piotr Rutkowski +26 more
Institutions Royal Marsden NHS Foundation Trust, Istituto Oncologico Veneto, Istituti di Ricovero e Cura a Carattere Scientifico, University of Colorado Denver, University of Colorado Cancer Center +31 more
Cites: 14
Cited by: 3,102
Related to: 10
FWCI: 218.1
Citation percentile (by year/subfield): 100
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Zero hunger
Open Access status: bronze